NMR spectroscopy reveals unexpected structural variation at the protein-protein interface in MHC class i molecules

Journal of Biomolecular NMR

Volumn 57, Issue 2, 2013, Pages 167-178

  Beerbaum, Monika ^a   Ballaschk, Martin ^a   Erdmann, Natalja ^a   Schnick, Christina ^b   Diehl, Anne ^a   Uchanska Ziegler, Barbara ^b   Ziegler, Andreas ^b   Schmieder, Peter ^a  

^a LEIBNIZ INSTITUT FÜR MOLEKULARE PHARMAKOLOGIE   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

2 Microglobulin; HLA B27 subtypes; Labeling; MHC class I; NMR assignment; Protein expression; Protein flexibility

Indexed keywords

BETA 2 MICROGLOBULIN; HLA B ANTIGEN; HLA B27 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TRYPTOPHAN;

ANKYLOSING SPONDYLITIS; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; HEAVY CHAIN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTON NUCLEAR MAGNETIC RESONANCE; SPONDYLOARTHROPATHY;

AMINO ACID SEQUENCE; BETA 2-MICROGLOBULIN; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-B27 ANTIGEN; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PEPTIDES; PROTEIN BINDING; TRYPTOPHAN;

EID: 84892911136     PISSN: 09252738     EISSN: 15735001     Source Type: Journal    
DOI: 10.1007/s10858-013-9777-z     Document Type: Article

References (67)

1. Baker BM, Scott DR, Blevins SJ, Hawse WF (2012) Structural and dynamic control of T-cell receptor specificity, cross-reactivity, and binding mechanism. Immunol Rev 250:10-31
2. Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC (1987) Structure of the human class I histocompatibility antigen, HLA-A2. Nature 329:506-512
3. Borbulevych OY, Piepenbrink KH, Gloor BE, Scott DR, Sommese RF, Cole DK, Sewell AK, Baker BM (2009) T cell receptor cross-reactivity directed by antigen-dependent tuning of peptide-MHC molecular flexibility. Immunity 31:885-896
4. Brown MA (2011) Progress in the genetics of ankylosing spondylitis. Brief Funct Genomics 10:249-257
5. Cavanagh J, Palmer AG III, Skelton NJ (1996) Protein NMR spectroscopy, principles and practice. Academic Press, San Diego
6. Cohen LS, Becker JM, Naider F (2010) Biosynthesis of peptide fragments of eukaryotic GPCRs in Escherichia coli by directing expression into inclusion bodies. J Pept Sci 16:213-218
7. D'Amato M, Fiorillo MT, Carcassi C, Mathieu A, Zuccarelli A, Bitti PP, Tosi R, Sorrentino R (1995) Relevance of residue 116 of HLA-B27 in determining susceptibility to ankylosing spondylitis. Eur J Immunol 25:3199-3201
8. DeLano WL (2002) The PyMOL Molecular Graphics System. San Carlos, CA, DeLano Scientific
9. Eichner T, Kalverda AP, Thompson GS, Homans SW, Radford SE (2011) Conformational conversion during amyloid formation at atomic resolution. Mol Cell 41:161-172
10. Esposito G, Ricagno S, Corazza A, Rennella E, Gumral D, Mimmi MC, Betto E, Pucillo CE, Fogolari F, Viglino P, Raimondi S, Giorgetti S, Bolognesi B, Merlini G, Stoppini M, Bolognesi M, Bellotti V (2008) The controlling roles of Trp60 and Trp95 in beta2-microglobulin function, folding and amyloid aggregation properties. J Mol Biol 378:887-897
11. Fabian H, Huser H, Narzi D, Misselwitz R, Loll B, Ziegler A, Böckmann RA, Uchanska-Ziegler B, Naumann D (2008) HLAB27 subtypes differentially associated with disease exhibit conformational differences in solution. J Mol Biol 376:798-810
12. Fabian H, Huser H, Loll B, Ziegler A, Naumann D, Uchanska-Ziegler B (2010) HLA-B27 heavy chains distinguished by a micropolymorphism exhibit differential flexibility. Arthritis Rheum 62: 978-987
13. Fabian H, Loll B, Huser H, Naumann D, Uchanska-Ziegler B, Ziegler A (2011) Influence of inflammation-related changes on conformational characteristics of HLA-B27 subtypes as detected by IR spectroscopy. FEBS J 278:1713-1727
14. Fiedler S, Knocke C, Vogt J, Oschkinat H, Diehl A (2007) HCDF as a protein labeling methodology. Genet Eng Biotechnol News 27. http://www. genengnews.com/gen-articles/hcdf-as-a-proteinlabeling-methodology/2090/
15. Fiorillo MT, Rückert C, Hülsmeyer M, Sorrentino R, Saenger W, Ziegler A, Uchanska-Ziegler B (2005) Allele-dependent similarity between viral and self-peptide presentation by HLA-B27 subtypes. J Biol Chem 280:2962-2971
16. Gao GF, Tormo J, Gerth UC, Wyer JR, McMichael AJ, Stuart DI, Bell JI, Jones EY, Jakobsen BK (1997) Crystal structure of the complex between human CD8alpha (alpha) and HLA-A2. Nature 387:630-634
17. Garboczi DN, Hung DT, Wiley DC (1992) HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. Proc Natl Acad Sci USA 89:3429-3433
18. Garcia KC, Degano M, Pease LR, Huang M, Peterson PA, Teyton L, Wilson IA (1998) Structural basis of plasticity in T cell receptor recognition of a self peptide-MHCantigen. Science 279:1166-1172
19. Giovanni R (1961) The effects of deuterium oxide on bacteria. Mol Gen Genet 402:389-402
20. Goddard TD, Kneller DG (2004) SPARKY 3. University of California, San Francisco
21. Gras S, Kjer-Nielsen L, Chen Z, Rossjohn J, McCluskey J (2011) The structural bases of direct T-cell allorecognition: implications for T-cell-mediated transplant rejection. Immunol Cell Biol 89: 388-395
22. Günther S, Schlundt A, Sticht J, Roske Y, Heinemann U, Wiesmüller KH, Jung G, Falk K, Rotzschke O, Freund C (2010) Bidirectional binding of invariant chain peptides to an MHC class II molecule. Proc Natl Acad Sci USA 107:22219-22224
23. Hammer RE, Maika SD, Richardson JA, Tang JP, Taurog JD (1990) Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders. Cell 63:1099-1112
24. Hare BJ, Wyss DF, Osburne MS, Kern PS, Reinherz EL, Wagner G (1999) Structure, specificity and CDR mobility of a class II restricted single-chain T-cell receptor. Nat Struct Biol 6:574-581
25. Hawse WF, Champion MM, Joyce MV, Hellman LM, Hossain M, Ryan V, Pierce BG, Weng Z, Baker BM (2012) Cutting edge: evidence for a dynamically driven T cell signaling mechanism. J Immunol 188:5819-5823
26. Hee CS, Beerbaum M, Loll B, Ballaschk M, Schmieder P, Uchanska-Ziegler B, Ziegler A (2013) Dynamics of free versus complexed beta2-microglobulin and the evolution of interfaces in MHC class I molecules. Immunogenetics 65:157-172
27. Hodkinson JP, Jahn TR, Radford SE, Ashcroft AE (2009) HDX-ESIMS reveals enhanced conformational dynamics of the amyloidogenic protein beta(2)-microglobulin upon release from the MHC-1. J Am Soc Mass Spectrom 20:278-286
28. Horton R, Wilming L, Rand V, Lovering RC, Bruford EA, Khodiyar VK, Lush MJ, Povey S, Talbot CC Jr, Wright MW, Wain HM, Trowsdale J, Ziegler A, Beck S (2004) Gene map of the extended human MHC. Nat Rev Genetics 5:889-899
29. Hülsmeyer M, Hillig RC, Volz A, Ruhl M, Schröder W, Saenger W, Ziegler A, Uchanska-Ziegler B (2002) HLA-B27 subtypes differentially associated with disease exhibit subtle structural alterations. J Biol Chem 277:47844-47853
30. Hülsmeyer M, Fiorillo MT, Bettosini F, Sorrentino R, Saenger W, Ziegler A, Uchanska-Ziegler B (2004) Dual, HLA-B27 subtypedependent conformation of a self-peptide. J Exp Med 199: 271-281
31. Hülsmeyer M, Welfle K, Pöhlmann T, Misselwitz R, Alexiev U, Welfle H, Saenger W, Uchanska-Ziegler B, Ziegler A (2005) Thermodynamic and structural equivalence of two HLA-B27 subtypes complexed with a self-peptide. J Mol Biol 346: 1367-1379
32. Insaidoo FK, Zajicek J, Baker BM (2009) A general and efficient approach for NMR studies of peptide dynamics in class I MHC peptide binding grooves. Biochemistry 48:9708-9710
33. Kjer-Nielsen L, Clements CS, Purcell AW, Brooks AG, Whisstock JC, Burrows SR, McCluskey J, Rossjohn J (2003) A structural basis for the selection of dominant alphabeta T cell receptors in antiviral immunity. Immunity 18:53-64
34. Kumar P, Vahedi-Faridi A, Saenger W, Ziegler A, Uchanska-Ziegler B (2009) Conformational changes within the HLA-A1:MAGEA1 complex induced by binding of a recombinant antibody fragment with TCR-like specificity. Protein Sci 18:37-49
35. Kushner DJ, Baker A, Dunstall TG (1999) Pharmacological uses and perspectives of heavy water and deuterated compounds. Can J Physiol Pharmacol 77:79-88
36. Leiting B, Marsilio F, O'Connell JF (1998) Predictable deuteration of recombinant proteins expressed in Escherichia coli. Anal Biochem 265:351-355
37. MacFerrin KD, Terranova MP, Schreiber SL, Verdine GL (1990) Overproduction and dissection of proteins by the expressioncassette polymerase chain reaction. Proc Natl Acad Sci USA 87:1937-1941
38. Madden DR (1995) The three-dimensional structure of peptide-MHC complexes. Annu Rev Immunol 13:587-622
39. Madden DR, Gorga JC, Strominger JL, Wiley DC (1992) The threedimensional structure of HLA-B27 at 2.1 A resolution suggests a general mechanism for tight peptide binding to MHC. Cell 70:1035-1048
40. Marley J, Lu M, Bracken C (2001) A method for efficient isotopic labeling of recombinant proteins. J Biomol NMR 20:71-75
41. Michielin O, Karplus M (2002) Binding free energy differences in a TCR-peptide-MHC complex induced by a peptide mutation: a simulation analysis. J Mol Biol 324:547-569
42. Mittermaier A, Kay LE (2006) New tools provide new insights in NMR studies of protein dynamics. Science 312:224-228
43. Mittermaier AK, Kay LE (2009) Observing biological dynamics at atomic resolution using NMR. Trends Biochem Sci 34:601-611
44. Narzi D, Becker CM, Fiorillo MT, Uchanska-Ziegler B, Ziegler A, Böckmann RA (2012) Dynamical characterization of two differentially disease associated MHC class I proteins in complex with viral and self-peptides. J Mol Biol 415:429-442
45. Okon M, Bray P, Vucelic D (1992) 1H NMR assignments and secondary structure of human beta 2-microglobulin in solution. Biochemistry 31:8906-8915
46. Paliy O, Bloor D, Brockwell D, Gilbert P, Barber J (2003) Improved methods of cultivation and production of deuteriated proteins from E. coli strains grown on fully deuteriated minimal medium. J Appl Microbiol 94:580-586
47. Pervushin K, Riek R, Wider G, Wüthrich K (1997) Attenuated T2 relaxation by mutual cancellation of dipole-dipole coupling and chemical shift anisotropy indicates an avenue to NMR structures of very large biological macromolecules in solution. Proc Natl Acad Sci USA 94:12366-12371
48. Pöhlmann T, Böckmann RA, Grubmüller H, Uchanska-Ziegler B, Ziegler A, Alexiev U (2004) Differential peptide dynamics is linked to major histocompatibility complex polymorphism. J Biol Chem 279:28197-28201
49. Reche PA, Reinherz EL (2003) Sequence variability analysis of human class I and class II MHC molecules: functional and structural correlates of amino acid polymorphisms. J Mol Biol 331:623-641
50. Reiser JB, Darnault C, Gregoire C, Mosser T, Mazza G, Kearney A, van der Merwe PA, Fontecilla-Camps JC, Housset D, Malissen B (2003) CDR3 loop flexibility contributes to the degeneracy of TCR recognition. Nat Immunol 4:241-247
51. Reveille JD (2012) Genetics of spondyloarthritis - beyond the MHC. Nat Rev Rheumatol 8:296-304
52. Röben M, Hahn J, Klein E, Lamparter T, Psakis G, Hughes J, Schmieder P (2010) NMR spectroscopic investigation of mobility and hydrogen bonding of the chromophore in the binding pocket of phytochrome proteins. Chemphyschem: a European journal of chemical physics and physical chemistry 11: 1248-1257
53. Rognan D, Scapozza L, Folkers G, DaserA(1994) Molecular dynamics simulation of MHC-peptide complexes as a tool for predicting potential T cell epitopes. Biochemistry 33:11476-11485
54. Rückert C, Fiorillo MT, Loll B, Moretti R, Biesiadka J, Saenger W, Ziegler A, Sorrentino R, Uchanska-Ziegler B (2006) Conformational dimorphism of self-peptides and molecular mimicry in a disease-associated HLA-B27 subtype. J Biol Chem 281:2306-2316
55. Rudolph MG, Stanfield RL, Wilson IA (2006) How TCRs bind MHCs, peptides, and coreceptors. Annu Rev Immunol 24:419-466
56. Shi Y, Qi J, Iwamoto A, Gao GF (2011) Plasticity of human CD8alphaalpha binding to peptide-HLA-A*2402. Mol Immunol 48:2198-2202
57. Taurog JD (2009) Animal models of spondyloarthritis. Adv Exp Med Biol 649:245-254
58. Tugarinov V, Hwang PM, Kay LE (2004) Nuclear magnetic resonance spectroscopy of high-molecular-weight proteins. Annu Rev Biochem 73:107-146
59. Uchanska-Ziegler B, Ziegler A, Schmieder P (2013) Structural and dynamic features of HLA-B27 subtypes. Curr Opin Rheumatol 25:411-418
60. Varani L, Bankovich AJ, Liu CW, Colf LA, Jones LL, Kranz DM, Puglisi JD, Garcia KC (2007) Solution mapping of T cell receptor docking footprints on peptide-MHC. Proc Natl Acad Sci USA 104:13080-13085
61. Vranken WF, Boucher W, Stevens TJ, Fogh RH, Pajon A, Llinas M, Ulrich EL, Markley JL, Ionides J, Laue ED (2005) The CCPN data model for NMR spectroscopy: development of a software pipeline. Proteins 59:687-696
62. Wan S, Coveney P, Flower DR (2004) Large-scale molecular dynamics simulations of HLA-A*0201 complexed with a tumor-specific antigenic peptide: can the alpha3 and beta2 m domains be neglected? J Comput Chem 25:1803-1813
63. Winkler K, Winter A, Rueckert C, Uchanska-Ziegler B, Alexiev U (2007) Natural MHC class I polymorphism controls the pathway of peptide dissociation from HLA-B27 complexes. Biophys J 93:2743-2755
64. Yin Y, Mariuzza RA (2009) The multiple mechanisms of T cell receptor cross-reactivity. Immunity 31:849-851
65. Zacharias M, Springer S (2004) Conformational flexibility of the MHC class I alpha1-alpha2 domain in peptide bound and free states: a molecular dynamics simulation study. Biophys J 87:2203-2214
66. Zhu J, Rao H, Tonelli M, Westler WM, Singarapu KK, Markley JL, DeLuca HF, Assadi-Porter FM (2012) Efficient stable isotope labeling and purification of vitamin D receptor from inclusion bodies. Protein Expression Purif 85:25-31
67. Ziegler A, Loll B, Misselwitz R, Uchanska-Ziegler B (2009) Implications of structural and thermodynamic studies of HLAB27 subtypes exhibiting differential association with ankylosing spondylitis. Adv Exp Med Biol 649:177-195